220 related articles for article (PubMed ID: 28362190)
1. HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers.
Di Domenico M; Giovane G; Kouidhi S; Iorio R; Romano M; De Francesco F; Feola A; Siciliano C; Califano L; Giordano A
Cancer Biol Ther; 2018; 19(10):850-857. PubMed ID: 28362190
[TBL] [Abstract][Full Text] [Related]
2. Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer.
LeConte BA; Szaniszlo P; Fennewald SM; Lou DI; Qiu S; Chen NW; Lee JH; Resto VA
PLoS One; 2018; 13(8):e0203403. PubMed ID: 30161236
[TBL] [Abstract][Full Text] [Related]
3. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
5. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to cervical cancer: an overview.
de Freitas AC; Gurgel AP; Chagas BS; Coimbra EC; do Amaral CM
Gynecol Oncol; 2012 Aug; 126(2):304-11. PubMed ID: 22484226
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus: often harmless but in some cases carcinogenic.
Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review).
Jiménez-Wences H; Peralta-Zaragoza O; Fernández-Tilapa G
Oncol Rep; 2014 Jun; 31(6):2467-76. PubMed ID: 24737381
[TBL] [Abstract][Full Text] [Related]
10. Human papilloma virus (HPV) molecular diagnostics.
Kroupis C; Vourlidis N
Clin Chem Lab Med; 2011 Nov; 49(11):1783-99. PubMed ID: 21875401
[TBL] [Abstract][Full Text] [Related]
11. Oral-genital human papillomavirus infection in Polish couples: frequent detection of HPV 42.
Kiwerska K; Jozefiak A; Markowska J; Kedzia W; Jackowska J; Wierzbicka M
BMC Infect Dis; 2019 Feb; 19(1):122. PubMed ID: 30727957
[TBL] [Abstract][Full Text] [Related]
12. Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.
Zhu X; Li S; Luo J; Ying X; Li Z; Wang Y; Zhang M; Zhang T; Jiang P; Wang X
Front Immunol; 2022; 13():801639. PubMed ID: 35126391
[TBL] [Abstract][Full Text] [Related]
13. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study.
Naucler P; Mabota da Costa F; da Costa JL; Ljungberg O; Bugalho A; Dillner J
J Gen Virol; 2011 Dec; 92(Pt 12):2784-2791. PubMed ID: 21900420
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus (HPV) infections related to cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma of the uterine cervix.
Syrjänen KJ; Syrjänen SM
Ann Clin Res; 1985; 17(2):45-56. PubMed ID: 2994541
[TBL] [Abstract][Full Text] [Related]
16. Association of human papillomavirus related squamous cell carcinomas of the oropharynx and cervix.
Gazzaz MJ; Jeffery C; O'Connell D; Harris J; Seikaly H; Biron V
Papillomavirus Res; 2019 Dec; 8():100188. PubMed ID: 31629093
[TBL] [Abstract][Full Text] [Related]
17. Understanding the HPV integration and its progression to cervical cancer.
Oyervides-Muñoz MA; Pérez-Maya AA; Rodríguez-Gutiérrez HF; Gómez-Macias GS; Fajardo-Ramírez OR; Treviño V; Barrera-Saldaña HA; Garza-Rodríguez ML
Infect Genet Evol; 2018 Jul; 61():134-144. PubMed ID: 29518579
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
[No Abstract] [Full Text] [Related]
19. Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women.
Sedjo RL; Inserra P; Abrahamsen M; Harris RB; Roe DJ; Baldwin S; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):353-9. PubMed ID: 11927495
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer: A comprehensive approach towards extermination.
Bava SV; Thulasidasan AK; Sreekanth CN; Anto RJ
Ann Med; 2016; 48(3):149-61. PubMed ID: 26911282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
